Loading chat...
GA HR1133
Resolution
Status
Passed
2/29/2024
Primary Sponsor
Billy Mitchell
Click for details
AI Summary
- Urges the U.S. Congress to pass the Kidney PATIENT Act of 2023 (H.R. 5074) to ensure end-stage renal disease (ESRD) patients continue to have access to essential oral-only medications
- Opposes CMS's proposed 2025 change to exclude separate Medicare Part D payment for oral-only phosphate lowering therapies (PLTs) and instead bundle them into the ESRD prospective payment system, which would threaten medication accessibility and affordability for dialysis patients
- Warns that shifting PLT payment from Part D to the ESRD bundled payment system would disproportionately impact minority and low-income communities in Georgia, where kidney failure patients already face challenges from comorbidities such as diabetes and hypertension
- The federal Kidney PATIENT Act (H.R. 5074), introduced with bipartisan support by U.S. Representatives Carter, Kuster, Miller, and Sewell, would delay the inclusion of oral-only drugs in the ESRD prospective payment system until 2033 or until new intravenous therapies become available
- Directs the Clerk of the Georgia House of Representatives to distribute copies of the resolution to congressional leadership and all members of the Georgia Congressional delegation
Legislative Description
Congress; pass Kidney PATIENT Act of 2023; urge
Last Action
Senate Withdrawn & Recommitted
3/18/2024
Committee Referrals
Judiciary3/4/2024
Health2/15/2024
Full Bill Text
No bill text available